Floatz logo

Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells

Multiple System Atrophy

Indonesia UniversityCell therapyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

27 Active assets in the Multiple System Atrophy cohort.

Asset / SponsorPhaseRating
Droxidopa
Loma Linda University
Phase 3BB
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BB
ATH-434
Alterity Therapeutics
Phase 2B
IOFLUPANE
GE Healthcare
Phase 3B
Riluzole
King's College London
Phase 3B

View all 40 →

Same molecule, other indications

Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells is also rated in:

cerebral infarctionDormant
CCC
Indicative ·
50 / 100
View asset →
cirrhosis of liverDormant
CCC
Indicative ·
48 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →